The global Cardiac Biomarkers Market was valued at USD 20.8 billion in 2025 and is projected to grow from USD 23.0 billion in 2026 to USD 49.3 billion by 2033, registering a CAGR of 11.5% from 2026 to 2033. North America dominated the global market with a 43.3% revenue share in 2025, driven by the high prevalence of cardiovascular diseases (CVDs), widespread adoption of advanced...

The global Lateral Flow Assays (LFA) Market  was valued at USD 10.2 billion in 2025 and is projected to grow from USD 10.6 billion in 2026 to USD 17.4 billion by 2033, registering a CAGR of 7.4% from 2026 to 2033. The market is witnessing sustained growth due to the increasing demand for rapid, affordable, and easy-to-use diagnostic solutions across clinical, point-of-care (POC),...

The United States remains a key contributor to the Digital Subtraction Angiography Equipment Market, supported by its advanced healthcare system, rapid adoption of innovative medical imaging technologies, and increasing demand for minimally invasive diagnostic and interventional procedures. The rising prevalence of cardiovascular diseases, stroke, peripheral artery disease, and neurovascular...